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Abstract
Introduction 
Overweight and obesity are public health issues in the United States, and veterans have a higher rate of overweight and 
obesity than the general population. Our objective was to examine whether copayment elimination increased use of a 
weight loss clinic by veterans.
Methods 
We examined clinic use by 44,411 new patients seen in a Veterans Affairs (VA) MOVE! weight management clinic before 
the copayment elimination and clinic use by 64,398 new patients seen in the year after copayment elimination. We 
examined clinic use via mixed-effects models for patients who were already exempt from copayment and patients who 
were newly exempt from copayment. We used 2 outcomes before and after copayment elimination: 1) the ratio of 
number of clinic visits by new users with the mean number of MOVE! clinic visits by all users, and 2) the number of 
clinic visits by each new user in the 6 months after their first visit. All models were adjusted for patient and clinic 
factors.
Results 
Among newly exempt patients, the clinic-standardized rate of new use increased by 2.2% after the copayment was 
eliminated but increased 12% among already exempt veterans. This finding was confirmed in adjusted analyses. 
Analysis of number of clinic visits adjusted for patient and clinic factors also found that exempt and nonexempt veterans 
had similar numbers of repeat clinic visits.
Conclusion 
We saw an unexpected larger increase in demand among veterans who receive all VA care for free. These results suggest 
that VA should not assume that copayment reductions for selective preventive services will motivate patient change and 
achieve intended system-level outcomes.
Introduction
Obesity is a major health and health care problem; more than one-third of Americans are currently obese and another 
approximately one-third are overweight (1). Obesity is associated with chronic, debilitating illnesses (2) and was the 
second leading cause of preventable deaths in the United States in 2005 (3). Excess weight is also costly, resulting in an 
estimated $75 to $93 billion in annual medical care expenditures (4). Veterans have a higher rate of overweight and 
obesity than the general population (5). Moreover, obesity rates were higher among veterans who obtained care partially 
(28%) or exclusively (31%) in Veterans Affairs Medical Centers (VAMCs) than veterans who did not use VA services 
(24%).
Despite widespread dissemination of evidence-based weight management recommendations, only 20% of people trying 
to lose weight adhere to guidelines on dietary intake and physical activity (6). Patients who successfully lose weight 
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typically regain much of that weight after 1 year and nearly all of it by 5 years (7). Therefore, the US Preventive Services 
Task Force has recommended only high-intensity counseling interventions (at least 2 person-to-person sessions per 
month for at least the first 3 months of an intervention) (8).
To address the increasing prevalence of overweight and obesity in veterans, the Veterans Health Administration (VHA) 
developed the MOVE! Weight Management Program for veterans in 2006. The program provides a systematic, evidence
-based approach to weight management for the nearly 6 million veterans served by approximately 153 hospitals and 956 
outpatient clinics (9). MOVE! uses a pretreatment intake questionnaire (http://www.move.va.gov/move23.asp) to 
develop tailored, behaviorally based dietary changes and physical activity self-management support that are delivered 
through individual or group face-to-face counseling and that are supported with interventions that use weight loss 
medications, intensive outpatient programs, and bariatric surgery. More than 40% of veterans who participated in at 
least 2 MOVE! treatment sessions lost at least 5% of their body weight in the short term; only 12.5% of nonparticipants 
matched for age, sex, comorbidities, and body mass index lost this amount (10).
In 2006, a $15 copayment was required by veterans for all face-to-face MOVE!-related clinic visits if they did not meet 
disability or income thresholds for copayment exemption. Veterans were exempt from copayments for MOVE! clinic 
visits if they had sufficient military-service–related disability or had a low income (“always exempt”). On June 15, 2008, 
VHA policy makers eliminated the copayment because patients and clinic staff expressed concern that the copayment 
was a barrier to initial and ongoing participation. The copayment change was communicated to VA staff at local sites 
but not to veterans through a coordinated national communications strategy. The policy to eliminate copayments is 
consistent with value-based insurance design principles that link cost sharing directly to clinical value so that cost-
effective or cost-saving products and services have lower copayments than less cost-effective products and services (11). 
Value-based insurance design may become more prevalent because it was mandated per section 2713 of the Patient 
Protection and Affordable Care Act of 2010 (12). Studies have examined the effect of copayment elimination on 
medication use, but none have examined the effect of copayment elimination on weight loss service use.
The objective of this study was to evaluate the effect of the MOVE! copayment elimination on use of the MOVE! clinic by 
patients who had not previously received MOVE! clinic services. We examined whether the ratio of first-time MOVE! 
clinic visits to mean overall clinic use (ie, the clinic-standardized rate of new use) increased after the copayment was 
eliminated. We also examined whether new users increased the number of visits they made to the MOVE! clinic in the 6 
months after their first visit.
Methods
Design
The Durham VAMC Human Subjects Protection committee reviewed and approved this study. We employed a cross-
sectional pre–post study design with a nonequivalent control group. We had 2 distinct and nonoverlapping cross-
sectional cohorts: 1) a preperiod (June 16, 2007, through June 15, 2008) cohort of veterans who were new MOVE! clinic 
users in the year before the copayment elimination and 2) a postperiod (June 16, 2008, through June 15, 2009) cohort 
of veterans who were new MOVE! clinic users in the year after the copayment elimination. No patients in the preperiod 
cohort were represented in the postperiod cohort. Patients were identified as new users if they had no MOVE! clinic use 
in the 12 months before the index visit (their first MOVE! clinic visit) in the preperiod or postperiod. The cohort 
included incident, rather than prevalent, MOVE! users to enable us to identify immediate effects (13) of the copayment 
elimination among a subgroup of MOVE! users who may have been more responsive to the policy change.
Although nonexempt veterans during the preperiod were required to pay a $15 copayment until the copayment was 
eliminated on June 15, 2008, for the purpose of this study we refer to veterans in the preperiod (and the postperiod) 
who did not meet requirements for exemption and for whom the MOVE! copayment was eliminated as the “newly 
exempt” cohort. We hypothesized that copayment elimination would most affect the behavior of new clinic users in the 
postperiod. We compared MOVE! clinic visits by newly exempt veterans to clinic visits by a subgroup of veterans in the 
preperiod and postperiod cohorts who were exempt from copayments for all outpatient clinic visits. Seventeen percent 
of the preperiod cohort were veterans who were required to pay copayments, and 16% of the postperiod cohort were 
newly exempt veterans who became newly exempt in the year after copayment elimination.
Sample
The sample included 126 VAMCs with high-volume MOVE! clinics, defined as having 30 or more MOVE! participants 
during the preperiod. This threshold was chosen to identify VAMCs that had moved beyond the start-up phase of 
MOVE! implementation. For the clinic-standardized rate of new MOVE! use, we aggregated data to the clinic level by 
month for new users in the preperiod and the postperiod. The number of MOVE! visits by new users in the 6 months 
after their index visit was defined for 21,193 preperiod and 26,520 postperiod new users. We excluded 23,218 preperiod 
new users from the analysis of attendance precopayment and postcopayment removal because their first MOVE! clinic 
visit occurred within 6 months of the copayment elimination (between December 16, 2007, and June 14, 2008), so they 
had less than 6 months of preperiod time to make a repeat visit. We excluded 37,878 postperiod new users whose first 
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visit occurred between December 16, 2008, and June 14, 2009, for parallel cohort construction. The final sample 
included 44,411 preperiod and 64,398 postperiod new users.
Data sources and measures
To construct the 2 MOVE! clinic use outcomes and most patient characteristics (age, sex, race, copayment exemption 
status, and marital status), we used 2006–2009 VHA Outpatient Care File data, which contains information on every 
VHA outpatient visit. The first clinic use outcome was measured monthly at the clinic level separately for exempt and 
newly exempt users (126 clinics × [24 months × 2 copay groups] = 6,048) during the preperiod. This outcome was a 
ratio in which the numerator was the number of MOVE! first-time visits within each clinic by patients who were new 
users, and the clinic-specific denominator was the overall mean monthly number of MOVE! visits to that clinic. This 
ratio, which we refer to as the clinic-standardized rate of new MOVE! use, represents the ratio of first-time MOVE! 
clinic visits to mean overall clinic use by all users (prior users and new users). The denominator was constant during the 
24 months and the 2 copay groups, ranging from 0.0 to 4.3, so the ratio varied only according to the monthly change in 
the number of veterans who were using the MOVE! clinic for the first time. The denominator reflected the overall mean 
number of MOVE! clinic visits, so it was possible for the number of MOVE! clinic visits by new users in a given month to 
be larger than the overall monthly mean preperiod use (eg, the ratio was greater than 1.0). The second use outcome was 
a count variable that measured at the patient level in both the preperiod and postperiod (n = 47,713), and consisted of 
the number of MOVE! visits by new users in the 6 months after their first clinic visit.
To control for comorbidity, we obtained Diagnostic Cost Group (DCG) risk-adjustment scores for each patient in the 
preperiod and postperiod cohorts. DCG scores have been as predictive of veterans’ 1-year expenditures and mortality as 
other comorbidity scores (14,15). Patient characteristics were aggregated to the clinic level for assessing new users 
because the outcomes and unit of analysis were clinic-year. Finally, we obtained details on MOVE! clinic characteristics 
from VHA MOVE! annual reports. This report, required by VHA, completed by each facility’s MOVE! coordinator, and 
reviewed by facility leadership before submission, measures program implementation and MOVE! staffing levels at each 
VAMC. We selected clinic-level characteristics that may affect a clinic’s ability to meet new demand that resulted from 
elimination of the MOVE! copayment, including having a local MOVE! coordinator, the coordinating committee’s make-
up and linkage to primary care, and the availability of facility space for meetings and exercise sessions.
Analysis
The analysis for the first outcome was a linear mixed-effects model based on the framework of a split-plot design (16). 
In this design, the clinic was the “whole plot,” and the 2 factors (treatments) of interest were exempt versus nonexempt 
and preperiod versus postperiod (ie, copayment elimination phase), where exempt versus nonexempt is the “whole plot 
factor” and preperiod versus postperiod is the “subplot factor.” Therefore, the linear mixed-effects model included fixed 
effects for copayment exemption status, copayment elimination phase (ie, preperiod or postperiod), and their 
interaction; and random effects for clinic and the clinic by copayment exemption status interaction. We included a third 
random effect for month, nested in the copayment exemption status by copayment elimination phase interaction. This 
model also controlled for clinic average age, average DCG score, proportion female, proportion white, and proportion 
married as additional fixed effects in the model.
We used a negative binomial mixed-effects model to estimate differences in the number of MOVE! clinic visits. The 
fixed effects in the model included the main factors of interest: an indicator for copayment eligibility, an indicator for 
the preperiod or postperiod cohort, and an interaction of the copay eligibility and pre–post indicators. This interaction 
term indicates whether use of the MOVE! clinic changed significantly in exempt vs nonexempt veterans between the 
preperiod and postperiod. Additional fixed effects included veterans’ age, DCG score, sex, race, and marital status. A 
clinic-level random effect was included in the model to account for the intraclass correlation of patients from the same 
clinic. All analyses were conducted using SAS version 9.2 (SAS Institute, Inc, Cary, North Carolina) and Stata version 10 
(StataCorp LP, College Station, Texas).
Results
Ratio of first-time MOVE! clinic visits to mean overall clinic use by all users
During the year before the copayment elimination, the mean clinic-standardized rate of new MOVE! clinic use was 
higher for new users who were copayment exempt (18.0%) than for those required to pay copayments (3.6%), which 
suggests that for every 2 nonexempt veterans newly using MOVE! in the preperiod, 10 exempt veterans newly used 
MOVE! The mean clinic-standardized rate by veterans exempt from copayments and new to the MOVE! program 
increased from 18% to 30% of all clinic visits, while the mean clinic-standardized rate by veterans formerly required to 
pay copayments and new to the MOVE! program increased from 3.6% to 5.8%. Compared with nonexempt new users, 
the relative increase in the clinic-standardized rate new MOVE! clinic visits by exempt veterans was 12% in the year 
before the copayment elimination and 2.2% after. In the adjusted analysis (Table 1), we found a significant interaction 
between copayment elimination phase and copayment exemption status (−0.10, 95% confidence interval [CI], −0.15 to 
−0.04).
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Number of MOVE! clinic visits by new users
In the preperiod and postperiod, compared with nonexempt patients, exempt patients were younger (mean age, 55 y vs 
63 y), more likely to be female (12% vs 7%), less likely to be white (50% vs 54%), and less likely to be married (52% vs 
70%) and had higher mean DCG scores (0.75 vs 0.61) (all P < .001, Table 2). The unadjusted mean number of MOVE! 
clinic visits in the 6 months after the first visit was 3.64 (standard deviation [SD] = 4.55) by exempt veterans and 3.63 
(SD = 4.22) by nonexempt veterans in the preperiod and 3.59 (SD = 4.82) and 3.60 (SD = 4.97) in the postperiod, which 
corresponds to $54 per person ($15/visit × 3.6 visits) in waived copayments.
On the basis of the interaction between newly exempt and postperiod indicators in the adjusted analysis, we found no 
change from the preperiod to postperiod in the number of visits by new users who were exempt versus those who were 
required to pay copayments (Table 3). Veterans in the postperiod had a lower visit rate (0.98; 95% CI, 0.96-0.99) to 
MOVE! clinics than veterans in the preperiod. Visit rates were higher among female veterans than male veterans (1.12; 
95% CI, 1.10–1.15), among married veterans than unmarried veterans (1.04; 95% CI, 1.02–1.05), and among white 
veterans than nonwhite veterans (1.13; 95% CI, 1.11–1.15).
Discussion
We examined the effect of eliminating the $15 MOVE! clinic copayment on veterans’ demand for MOVE! services and 
found a modest but not significant increase in MOVE! clinic use by veterans newly exempt from the MOVE! clinic 
copayment. The lack of significant increased use by newly exempt veterans is surprising; prior studies have shown 
copayment elimination to be associated with increased medication adherence (11) and financial incentives to be 
associated with initiation of exercise and weight loss (17–19). Several studies have also shown health club vouchers or 
direct payments to be associated with increased overall physical activity level (18–20), particularly when coupled with a 
series of motivational interviews (21). Financial incentives in a structured work health program increased exercise levels 
in high-risk patients but had little response among lower-risk patients (22). The pool of newly exempt veterans wanting 
to attend MOVE! clinic visits may have been limited, so the clinic-standardized rate of 5.8% by these veterans satisfied 
this previously unmet demand.
The increase in MOVE! clinic use in the year after copayment elimination among both exempt and nonexempt veterans 
may have resulted from the continued efforts to promote the MOVE! program since 2006, rather than a direct result of 
the copayment elimination. The introduction of an obesity screening quality indicator in the latter half of 2008 (when 
the postperiod started) may have increased demand for MOVE! services by both patients and VHA clinicians. The 
increase in MOVE! use by exempt veterans after copayment elimination suggests that VHA does not need to be 
concerned about “a run on services” following copayment elimination. Exempt veterans may have used MOVE! at a 
higher rate than newly exempt veterans because they have greater VA use in general. To increase MOVE! use among 
newly exempt veterans, VA may want to consider direct financial incentives to veterans instead of a copayment 
reduction. A copayment reduction may be less motivating to individuals compared with a deposit contract approach 
(23), direct payments for weight reduction (19,24), or discounting of fitness services (25). Provision of financial 
incentives may be more effective for initiation of MOVE! visits than for intense and sustained MOVE! use (18,26), and 
incentives also might be more effective if combined with provider-level interventions.
This study has several limitations. First, these results may not generalize to MOVE! clinics that had low volume in the 
year before the copayment elimination or to more recent years (ie, mid-2009 and after). Second, we do not have 
baseline obesity and overweight status for the exempt and nonexempt groups. Higher-income, nonexempt veterans may 
have had fewer candidates for participation in the MOVE! program, which could account for the lower enrollment 
increase in that population. Third, we did not have data on the number of veterans who wanted to participate in the 
MOVE! program but were unable to participate. If a disproportionate share of veterans required to pay copayments 
were placed on waiting lists to enroll in MOVE!, these results would underestimate the response to the copayment 
elimination by these veterans because they only reflect actual MOVE! clinic visits. Fourth, there may have been changes 
in MOVE! clinics themselves over time that created maturation biases that potentially confounded the effect of the 
copayment elimination. Fifth, the examination of the MOVE! clinic copayment using a cross-sectional time-series study 
design of new MOVE! clinic users, some of whom were newly exempt veterans and some of whom were nonequivalent 
“always exempt” veterans, may have limited the internal validity of this evaluation. However, examination of MOVE! 
clinic demand by new users and inclusion of a control group (albeit nonequivalent) controlled for regression-to-the-
mean bias and other threats to internal validity.
Eliminating the copayment reduced a financial barrier to access the MOVE! clinic, yet we did not observe increased use 
by veterans newly exempt from these copayments compared with veterans who were already exempt from copayments. 
Unexpectedly, we saw a larger increase in demand among veterans who receive all VA care for free, which may have 
been driven by clinic staff perception of greater potential benefit of MOVE! clinic use in this segment of the population 
or by a greater perceived value of this exemption. Copayment elimination may be less important for health behavior 
change services that require ongoing commitment from patients. These results suggest that VA should not assume that 
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copayment reductions for selective preventive services will motivate patient change and achieve intended system-level 
outcomes.
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Tables 
 
Table 1. Adjusted Model Estimates (95% CI) of Clinic-Standardized Rate of 
New MOVE! Clinic Use
Variable Estimate (95% CI) P Value
Newly exempt −0.24 (−0.29 to −0.20) <.001
Postperiod 0.03 (−0.02 to 0.06) .22
Newly exempt × postperiod interaction −0.10 (−0.15 to −0.04) <.001
Average age of clinic patients 0.02 (0.01 to 0.02) <.001
Proportion female −0.004 (−0.006 to −0.002) <.001
Proportion married −0.0004 (−0.002 to 0.001) .54
Proportion white 0.001(−0.001 to 0.001) .25
Average comorbidity risk via diagnostic cost group score −0.38 (−0.48 to −0.28) <.001
MOVE! clinic coordinated by primary care −0.07 (−0.12 to −0.01) .01
MOVE! coordinated by a dietitian −0.02 (−0.07 to 0.02) .36
MOVE! coordinating committee includes . . .
a,b
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Variable Estimate (95% CI) P Value
Nonprimary care nurse 0.02 (−0.03 to 0.07) .45
Primary care physician 0.003 (−0.04 to 0.05) .91
Midlevel provider 0.04 (−0.01 to 0.09) .09
Health educator −0.01 (−0.06 to 0.04) .68
MOVE! clinic has sufficient space to meet needs 0.04 (−0.01 to 0.08) .09
MOVE! indoor exercise facility is sufficient to meet needs −0.03 (−0.09 to 0.03) .31
MOVE! outdoor exercise facility is sufficient to meet needs −0.03 (−0.08 to 0.02) .19
Distinct weight maintenance groups −0.05 (−0.09 to −0.004) .03
Sample size 6,048
Abbreviation: CI, confidence interval. 
 Estimates, 95% CIs and P values derived from linear mixed-effects model. Preperiod (June 16, 2007, through June 15, 
2008) is the cohort of veterans who were new MOVE! clinic users in the year before copayment elimination and postperiod 
(June 16, 2008, through June 15, 2009) is the cohort of veterans who were new MOVE! clinic users in the year after the 
copayment elimination. 
 The clinic-standardized rate of new MOVE! clinic use is defined as ratio in which the numerator was the number of MOVE! 
first-time visits within each clinic by patients who were new users, and the denominator was the overall mean monthly 
number of MOVE! visits to that clinic in the preperiod.
 
Table 2. Characteristics of Preperiod and Postperiod Cohorts of MOVE! 
Clinic Users
Characteristic
Preperiod
P 
Value
Postperiod
P 
Value
Copay 
Exempt
Newly 
Exempt
Copay 
Exempt
Newly 
Exempt
Age, mean (SD), y 55.3 (11.5) 62.7 (10.6) <.001 54.7 (11.6) 61.2 (10.8) <.001
Female, % 12 7 <.001 12 8 <.001
White race, % 50 54 <.001 51 57 <.001
Married, % 52 70 <.001 49 65 <.001
Mean Diagnostic Cost Group 
score
0.75 (0.71) 0.61 (0.50) <.001 0.71 (0.68) 0.55 (0.45) <.001
Sample size 17,504 3,689 NA 22,145 4,375 NA
Abbreviation: NA, not applicable. 
 Preperiod (June 16, 2007, through June 15, 2008) is the cohort of veterans who were new MOVE! clinic users in the year 
before copayment elimination and postperiod (June 16, 2008, through June 15, 2009) is the cohort of veterans who were 
new MOVE! clinic users in the year after the copayment elimination. 
 Differences in age and Diagnostic Cost Group scores estimated via 2-sided t tests and differences in sex, race, and marital 
status estimated via χ  tests.
 
Table 3. Adjusted Model Estimates of Number of MOVE! Clinic Visits by New 
Users (N = 47,713)
Variable Estimate (95% CI) P Value
Newly exempt 0.97 (0.94–1.00) .06
Postperiod 0.98 (0.96–0.99) .02
Newly exempt × postperiod interaction 1.00 (0.96–1.04) .83
Age 1.005 (1.004–1.006) <.001
a
b
a
b
b
a
b
2
a
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Variable Estimate (95% CI) P Value
Female 1.12 (1.10–1.15) <.001
Married 1.04 (1.02–1.05) <.001
White race 1.13 (1.11–1.15) <.001
Comorbidity risk via diagnostic cost group score 1.01 (1.00–1.02) .16
MOVE! clinic coordinated by primary care 0.93 (0.90–0.97) .001
MOVE! coordinating committee includes . . .
Nonprimary care nurse 1.09 (1.04–1.13) <.001
Primary care physician 1.15 (1.11–1.20) <.001
Midlevel provider 0.98 (0.94–1.02) .36
MOVE! clinic has sufficient space to meet needs 1.25 (1.20–1.31) <.001
MOVE! indoor exercise facility is sufficient to meet needs 0.75 (0.71–0.79) <.001
Abbreviation: CI, confidence interval. 
 Estimates, 95% CIs, and P values derived from a negative binomial mixed-effects model.
 
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. 
Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or 
the authors' affiliated institutions. 
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